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1Abstract 
Rationale: Lung hypoplasia in congenital diaphragmatic hernia (CDH) appears to involve 
impaired alveolar septation. We hypothesized that disturbed deposition of elastin and 
expression of FGF18, an elastogenesis stimulus, occurs in CDH. 
Objectives: To document FGF18 and elastin in human CDH and ovine surgical and rat 
nitrofen models; to use models to evaluate the benefit of treatments. 
Methods: Human CDH and control lungs were collected post-mortem. Diaphragmatic hernia 
was created in sheep at 85d; fetal lungs were collected at 139d (term=145d). Pregnant rats 
received nitrofen at 12d; fetal lungs were collected at 21d (term=22d). Some of the sheep 
fetuses with hernia underwent tracheal occlusion (TO); some of the nitrofen-treated pregnant 
rats received vitamin A. Both treatments are known to promote lung growth.  
Main results: Coincidental with the onset of secondary septation, FGF18 protein increased 
3-fold in control human lungs, which failed to occur in CDH. FGF18 labeling was found in 
interstitial cells of septa. Elastin staining demonstrated poor septation and markedly 
decreased elastin density in CDH lungs. Consistently, lung FGF18 transcripts were 
diminished 60% and 83% by CDH in sheep and rats, respectively, and elastin density and 
expression were also diminished. TO and vitamin A restored FGF18 and elastin expression 
in sheep and rats, respectively. TO restored elastin density. 
Conclusions: Impaired septation in CDH is associated with decreased FGF18 expression 
and elastic fiber deposition. Simultaneous correction of FGF18 and elastin defects by TO and 
vitamin A suggests that defective elastogenesis may result, at least partly, from FGF18 
deficiency.  
Word count: 245 
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2INTRODUCTION 
Congenital diaphragmatic hernia (CDH) is a developmental abnormality that is associated 
with high mortality and morbidity because of respiratory insufficiency, due to lung hypoplasia 
and pulmonary hypertension (1). The incidence of CDH is about 1/3,000 live births. Despite 
changing concepts and methodology in treatment (2), mortality rate remains high (3, 4).  
CDH lungs present fewer and smaller airspaces, reduced radial alveolar count, and 
thicker alveolar septa (14). Clearly, this results in part from early impairment of airway 
branching (6), each bronchiolar end giving rise to a limited number of saccules. Changes in 
key control factors involved in branching morphogenesis have been consistently reported. 
The sonic hedgehog system was lowered at early stages in CDH and peaked later in both 
humans and a rat model of CDH induced by the herbicide nitrofen (7). Fibroblast growth 
factor (FGF) 10 was decreased in the nitrofen model (8). The expression of FGF7, known to 
control alveolar epithelial cell proliferation and differentiation, was decreased in the nitrofen 
model (8) and in a model of surgically-induced CDH in sheep (9).  
However, morphogenesis of distal lung, including alveolar septation, also seems to be 
impaired in CDH. This disorder appears as a common feature of hypoplastic lungs, whatever 
the leading cause. Thus, previous studies in human pulmonary hypoplasia of various origins, 
including hydrops fetalis, renal anomalies, oligohydramnios, and CDH, have established 
retarded acinar complexity and maturation (10, 11). Elastic fiber deposition, which is 
essential to build alveolar walls (16-18), was reported to be disturbed in human lung 
hypoplasia in association with oligohydramnios (15-17) or CDH (17), and experimentally, in 
drainage-induced lung hypoplasia in fetal sheep (18). Moreover, in the ovine model, alveolar 
hypoplasia occurred in the absence of reduction in bronchiolar generations, due to late 
creation of hernia (19), and discontinuous, uncondensed elastin aggregates have been 
described in alveolar septa (20). Decreased elastin expression with less elastin deposition 
and disorganized distribution, have also been reported in the nitrofen-model (21). 
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saccular and alveolar development. FGF18 is believed to play important role. Thus, lung-
targeted FGF18 overexpression inhibited distal lung development (22), whereas FGF18-null 
mouse fetuses displayed smaller distal airspaces and thickened septa (23). FGF18 
expression markedly increases coincidently with postnatal formation of secondary septa in 
the rat (24), and FGF18 enhances proliferation and elastogenesis in myofibroblasts (24), the 
source of septal elastin. Moreover, FGFR3 is a high-affinity receptor for FGF18 (25), and 
alveolarization is completely abolished in mice devoid of both FGFR3 and FGFR4 (26). Thus 
far, FGF18 has not been documented in the developing human lung, either in normal or 
pathological conditions. 
The potential benefit of two treatments aiming to restore lung development in CDH, 
namely tracheal occlusion and vitamin A administration, have been investigated in the 
surgical ovine model and in the rat nitrofen-model, respectively. In sheep fetuses with hernia 
as well as with lung hypoplasia induced by drainage, tracheal occlusion restored lung growth, 
increased gas exchange surface area (27-29), and ameliorated respiratory function at 
delivery (30, 31). It should be emphasized that this treatment is currently under trial in human 
fetuses with CDH (32). In the nitrofen model, vitamin A decreased the incidence and severity 
of CDH, enhanced lung growth, and restored lung maturation (33, 34).  
The first objective of the present study was to investigate whether CDH had impact 
upon FGF18 expression in the developing human lung and in models. Elastic fiber deposits 
and elastin expression were studied in parallel to further document qualitative and 
quantitative changes. The second objective consisted of using the sheep and rat models of 
CDH to evaluate the effects of tracheal occlusion and vitamin A-treatment, respectively, on 
pulmonary FGF18 expression and elastin deposition. Some of the results of these studies 
have been previously reported in the form of an abstract (35). 
(Word count: 632) 
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Human lung tissue 
Human lung samples were collected during the autopsy after medical terminations of 
pregnancy in bad-prognosis fetuses, or following death after delivery. Parents were informed 
about the procedure and issues of post-mortem study, and signed consent was obtained for 
all included patients.  The study received approval from the local Ethics Committee. Detailed 
clinical data are depicted in table 1.  
 
Sheep model of CDH and tracheal occlusion 
Surgical procedures have been extensively described elsewhere (36). Biological samples 
were collected from the same animals as in previous reports (20, 27). 
Nitrofen exposure in rats 
The procedure has been described in detail elsewhere (33). Pregnant Wistar rats were 
gavaged with nitrofen in olive oil on day 12. Control dams received olive oil. Vitamin A was 
gavaged on day 14. Fetuses were retrieved on day 21.  
 
Histochemical elastin staining and quantification 
Because of restrictions in human tissue sampling conditions, and of collection of sheep lung 
samples for multiple purposes (20, 27), lungs were not fixed at constant pressure. Human 
and sheep lungs tissue were fixed 24h after death and at sacrifice, respectively. Sections 
were stained for elastin with Weigert’s stain. Proportion of tissue surface-area occupied by 
elastic fibers was determined with Perfect Image v7.4 software. In each analyzed field, tissue 
area was determined by subtracting airspace surface-area from total surface-area. Stained 
elastic fiber surface-area was measured after exclusion of large vessel and airway elastin. 
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Sections were labeled using a polyclonal antibody raised in rabbit (AbCys S.A., Paris, 
France), and Cy3-conjugated donkey anti-rabbit IgG (Jackson ImmunoResearch, 
Newmarket, UK). 
 
RNA extraction 
Total RNA was extracted using Trizol reagent (Invitrogen, Cergy-Pontoise, France). Quality 
and integrity were confirmed after electrophoresis. 
 
Determination of ovine partial cDNA sequence for FGF18 
cDNAs were reverse-transcribed from sheep lung total RNAs, and partial amplification of 
partial cDNA sequence was performed using sense primer 5’- 
CTGCTGTGCTTCCAGGTTCA -3’ (mouse/rat FGF18-specific sequence, GenBank 
accession numbers NM008005 and NM019199, respectively) and antisense primer: 5’- 
CCGTCGTGTACTTGAAGGGC -3’ (human FGF18-specific sequence, GenBank accession # 
BC006245).  
 
Northern blot analysis 
Rat cDNA probes consisted of a 1,100-bp sequence for tropoelastin (gift from Dr. C. Rich, 
Philadelphia, PA) and a 904-bp sequence for FGF18 (gift from Dr. N. Itoh, Kyoto, Japan). 
Ovine tropoelastin cDNA probe was obtained by RT-PCR from RNA extracted from fetal 
sheep lung tissue, using ovine-specific oligonucleotide primers (37). Blots were exposed to 
X-Omat AR Kodak films, and signals were quantified by densitometry (NIH Image, Bethesda, 
MD). 
Reverse Transcription and Real-time quantitative PCR 
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FGF18 mRNA, FGFR3 mRNA, and internal reference 18S rRNA in ovine lungs. Primer 
sequences are reported in table 2. All measurements were performed in triplicate.  
 
Western blot analysis  
Membranes were exposed to goat anti-rhFGF18 antibody (R&D Systems, Lille, France) both 
diluted 1:500, washed in TTBS, then to horseradish peroxidase-conjugated donkey anti-goat 
IgG antibody (Santa Cruz Biotechnology, Santa Cruz, USA) and incubated in ECL reagent 
(Amersham Biosciences), before exposure to Kodak BioMax MS film. Signals were 
quantified by densitometry (NIH image). 
 
Statistical analysis 
Data are presented as mean ± se. Multiple group comparisons were made either by ANOVA 
and Fisher’s PLSD, or by non-parametric Kruskall-Wallis analysis, depending on applicability 
as detailed in results. Two-group comparisons were made by Student’s t test or by non-
parametric Man and Whitney’s U test, depending on applicability.  
(Word count: 550) 
 
RESULTS 
FGF18 in human lungs with CDH 
FGF18 protein was studied in human lung samples by western blot analysis. Preservation of 
RNA was not constant enough to perform study at pre-translational level. Because FGF18 
had never been documented in developing human lung, a first step consisted in studying 
changes in FGF18 level during the course of intra-uterine development. FGF18 proportion 
increased with progressing pregnancy between 14 to 37 wk (fetal age) with a particularly 
marked rise around 28 wk (Figure 1A). Densitometry analysis of data corrected for variations 
of protein loading (Figure 1B) indicated significant positive exponential correlation with time (r 
= 0.865; p<0.001). The highest amount observed between 32 and 37 wk (i.e. in early alveolar 
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about 10 times those at 19-21 wk (canalicular stage). Interestingly, when densitometric 
values were gathered into 2 groups corresponding to pre-saccular stages (T 26wk, n=6) and 
saccular-alveolar stages (age U 27 wk, n=8), mean FGF18 amount increased from 165 ± 69 
arbitrary units (a.U.) in the former to 782 ± 138.5 a.U. in the latter (p<0.01 by t test). Six pairs 
of CDH and age-matched control lungs ranging from 27 to 37 wk (saccular-alveolar stages) 
were then studied comparatively (Figure 2A). All CDH lungs ipsilateral to hernia displayed 
lower FGF18 level than their respective age-matched control, and FGF18 failed to increase 
in CDH samples over the period, whereas control values increased about 3 times (Figure 
2B). 
 
Elastin in human lungs with CDH 
Elastin staining was performed in 5 pairs of control and CDH lungs ranging from 27 to 37 wk.  
In control fetuses, lung parenchyma matured homogeneously during the period, with thinning 
of septal walls, increased proportion of airspaces, and surge of secondary septa as 
illustrated in Figure 3, A and C. Airspaces displayed regular distribution. Elastin staining 
demonstrated bundles beneath the surface of walls, and punctate, dense deposits at the tips 
of growing septa that considerably increased in number with maturation (Figure 3, A’ and C’). 
Consistent with previous reports, CDH lungs displayed thicker walls, and denser tissue 
(Figure 3, B and D). Elastin staining also demonstrated mostly bundles in thick septa with 
extreme paucity of tip deposits (Figure 3, B’ and D’), which illustrates deficient secondary 
septation. Lung vessels strongly stained for elastin and presented no noticeable difference 
between CDH and control lungs. Quantitative evaluation of parenchymal elastic fiber 
deposits was achieved by determination of the proportion of tissue surface-area occupied by 
elastin patches, excluding vessel and airway elastin (Table 3). The elastic fiber density was 
low at 27 and 29 wk with no difference between CDH and control lungs. It was considerably 
higher at 31, 33 and 37 wk in controls, but failed to increase in CDH lungs that all displayed 
much lower value than their respective age-matched controls. 
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Experimental groups were: surgical diaphragmatic hernia created at 85d (sDH, n=6, 
term=15d), sDH + tracheal occlusion (TO, n=4), and control group (n=5), all retrieved at 139d 
of gestation. The expression level of FGF18 in sheep lungs was determined at pre- and post-
translational levels. Since ovine FGF18 cDNA sequence had not been reported previously, a 
first step consisted of determining it after RT-PCR amplification. Sheep lung mRNAs were 
retro-transcribed and amplified using 2 oligonucleotide primers chosen in the human and 
mouse/rat cDNA sequences in regions proximate to 5’ and 3’ ends and conserved among 
species described thus far. This allowed amplification of a 531 bp product representing a 
partial sequence of ovine FGF18 corresponding to positions 49 through 579 of the 621 
nucleotide coding sequences of human, mouse and rat FGF18 (Figure 4A). Its predicted 
amino-acid sequence shared 99% homology with human, mouse, and rat FGF18 as shown 
by sequence alignment (Figure 4B). The ovine cDNA sequence then served to design 
oligonucleotide primers for use in real-time RT-PCR, to evaluate FGF18 expression level 
among the various experimental groups. We found a 60% reduction of FGF18 transcript in 
the lung ipsilateral to hernia in the sDH group compared to control group (Figure 5A). There 
was a trend toward a decrease of FGF18 mRNA level in contralateral lung as well, but the 
difference was not statistically significant. FGF18 mRNA level was increased to twice the 
control level in both ipsilateral and contralateral lungs in the sDH+TO group (Figure 5A). 
FGF18 was also appraised at the post-translational level through western blot analysis in 
ipsilateral lung. FGF-18 antibody raised against the human peptide recognized ovine FGF18 
at the same apparent molecular weight (Figure 5B). Densitometric analysis normalized for 
gel loading indicated values of 193.4 and 596.5, 23.3 and 70.1, and 1381.0 and 327.5 a.U. in 
controls, sDH, and sDH+TO, respectively. Consistent with mRNA findings, FGF18 protein 
was therefore decreased to very low level in sDH compared to controls, and re-established in 
sDH+TO.. Because FGFR3-FGFR4 double null mutation abolished alveolar septation in the 
mouse (26), and FGFR3 is a putative receptor of FGF18 (25), expression of the transcript of 
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by sDH, and although it tended to increase after TO, the difference was not statistically 
significant (Figure 5C).  
 
Elastin in sheep lungs with sDH and sDH+TO  
Elastin staining on sections from the lung ipsilateral to hernia showed changes in elastin 
deposition quite similar to those in human CDH. Control lungs displayed regularly distributed 
airspaces with thin parenchymal tissue and dense focal elastic fiber deposits localized 
primary at the tips of newly forming septa and lining alveolar walls (Figure 6A, A’). All sDH 
lungs appeared immature with thicker septa. Some presented regularly distributed airspaces 
with evenly distributed elastin fibers, but similar to human CDH lungs, secondary crests with 
typical punctate elastin deposit at the apex were rare (Figure 6B). Other subjects displayed 
zones of dilated airspaces among large zones of dense and thick parenchyma, with elastin 
deposits being confined to dilated airspaces and extremely scarce in dense areas (Figure 
6C). The paucity of elastin staining in dense areas, and its presence at the tip of septa in 
dilated ones indicate that the presence of dilated and non-dilated zones is not an artefactual 
consequence of absence of pressure fixation, but rather an actual feature of these lungs. In 
fetuses with sDH+TO, alveolarization appeared to be restored as indicated by reappearance 
of regular elastin lining and punctate elastin deposits located at the tip of crests, which 
presented an appearance similar to that observed in controls (Figure 6D, D’). Elastin in walls 
of blood vessels and airways did not appear to be altered in sDH and sDH+TO groups. 
Quantification of parenchymal elastic fiber density indicated dramatically reduced amounts in 
sDH lungs that were only one seventh those in control lungs; TO restored the proportion of 
elastin deposits to a level not significantly different from that in control lungs (Table 4). In 
addition, tropoelastin mRNA level was decreased about half in ipsilateral lung in the sDH 
group, but was unchanged in contralateral lung, and TO enhanced the level to twice that in 
controls in both ipsilateral and contralateral lungs (Figure 7), thus abolishing DH effect. 
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Expression of tropoelastin and FGF18 in rat lungs with induced CDH and CDH + vitA 
Nitrofen treatment resulted in lung hypoplasia in all fetuses, associated with a 60 to 70% 
incidence of right-sided CDH. Lung wet weights were 111.1 ± 1.0, 85.5 ± 1.9, and 67.7 ± 1.6 
mg in control fetuses (given olive-oil, the vehicle of nitrofen), nitrofen-treated fetuses without 
CDH, and nitrofen-treated fetuses with CDH, respectively (p<0.001 vs controls for both 
nitrofen-treated groups). Vitamin A increased lung growth without fully restoring control level 
in nitrofen-treated fetuses (97.8 ± 3.0 mg without CDH, and 76.0 ± 1.9 mg with CDH, p<0.05 
as compared with nitrofen-treated fetuses without vitA). Tropoelastin and FGF18 mRNAs 
were deeply decreased to about 13% and 17% of control levels, respectively, in fetuses with 
nitrofen-induced CDH as compared with controls (Figure 8). Similar decreases were 
observed also in nitrofen-treated fetuses without CDH (not shown), suggesting association 
with nitrofen-induced lung hypoplasia, either in the presence or absence of hernia. Vitamin A 
administration 2 days after nitrofen treatment prevented the drop of both tropoelastin and 
FGF18 mRNAs that displayed levels not significantly different from those in controls (Figure 
8). 
 
FGF18 immunolocalization in lung tissues 
This investigation was carried out in control lung tissues of the three species to define cell 
localization of FGF18. Figure 9 shows results obtained with the same anti-FGF18 antibody in 
distal lung tissue. Immunoreactivity appeared in parenchymal cells as a dotted labeling. 
Figure 9A depicts immunofluorescence micrograph of 37-wk fetal human lung tissue, 
indicating presence of FGF18 in septal cells. Epithelial airway cells were slightly labeled, 
whereas smooth muscle cells of small airways or arteries were negative. In bronchial 
cartilagenous plates, chondrocytes, which are known to express FGF18 (37), were also 
labeled (not shown). In 139d fetal sheep lung tissue (Figure 9C), labeling was similarly found 
in septa. Weak labeling was also present in airway epithelial cells (not shown), but was 
absent from airway and vascular smooth muscle cells. In the rat, we choose to study lung 
tissue on postnatal day 4 (Figure 9E), when FGF18 expression has been reported to be 
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elevated (24). FGF18 immunoreactivity was present in cells in the thickness of walls of 
primary as well as secondary septa (left and right inserts in Figure 9E, respectively). 
Distribution of FGF18 labeling appeared similar to that of elastin or alpha smooth muscle 
actin (Figure 9G).  
 
DISCUSSION 
We report that decreases of FGF18 expression and of elastic fiber deposition in alveolar 
septa characterize CDH in humans. The presence of similar features in two animal models 
allowed us to use the latter to evaluate the effects of potential therapeutic approaches on 
these abnormalities. Tracheal occlusion in the surgical model, and vitamin A treatment in the 
nitrofen model allowed nearly normal features to be recovered. The work supports further 
studies to determine the potential benefit of these treatments in promoting lung growth and 
maturation in the presence of diaphragmatic hernia. 
 
Limitations of the study 
Investigations in humans raise the question of control appropriateness. Only lung samples 
from subjects with other, non-pulmonary diseases, can be used as controls. This is clearly an 
unavoidable limitation of the present study that may introduce bias. For instance, FGF18 is 
known to be involved not only in lung development, but also in the formation of heart, bone, 
and central nervous system. Nevertheless, the fact that differences were demonstrated 
between CDH and control lungs, and were observed also in animal models of CDH suggests 
that abnormalities actually result from CDH. This underlines the usefulness of comparing 
human and model data. 
 
Lung expression of FGF18 is deficient in diaphragmatic hernia 
Lung hypoplasia associated with CDH is believed to result from a precocious arrest of 
bronchial branching (6). Development of distal lung, including saccules and alveoli, appears 
to be impaired also. Disturbed alveolar development appears to be a common feature of 
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hypoplastic lungs, including in the instance of CDH (10, 11, 15-17). Altogether, these 
disorders result in histological appearance of less than stated gestational age with less 
acinar complexity (5). Taking into account the recently demonstrated association of FGF18 
with alveolarization process, we investigated whether pulmonary FGF18 expression was 
affected in CDH lung. FGF18 was effectively shown to play a crucial role in development of 
murine distal lung. Similar to features seen in mice deficient in elastin (13), fewer and larger 
air sacs were observed in FGF18-deficient mouse fetuses (23). Although lethality at birth 
prevents one from studying alveolarization in FGF18-deficient mice, the involvement of 
FGF18 in secondary septation is supported by FGF18 up-regulation during the process in the 
rat (24), by elastogenesis-stimulating activity of FGF18 in fibroblasts (24), and by the crucial 
role of FGFR3-FGFR4 signaling for secondary septation (26). 
The expression pattern of FGF18 in the developing human lung had not been 
examined previously. A first step therefore consisted in studying FGF18 expression in the 
course of fetal lung development. A major observation of the present study was the marked 
increase in FGF18 protein, starting from 27-28 wk of gestation to reach elevated level at 36-
37 wk. Although the precise time when secondary alveolar septation begins in humans is a 
matter of debate, in part because of the difficulty in defining an alveolus in microscopic 
sections (12), it is generally accepted that the process starts between 30 and 36 wk. 
Therefore, FGF18 increases in human lung coincidently with starting secondary septation. 
This finding, consistent with studies in rodents, reinforces the assumption of involvement of 
FGF18 in alveologenesis. Moreover, FGF18 localization in interstitial cells of alveolar walls, 
presumably myofibroblasts, at sites and time of alveolarization and elastin deposition 
strongly argues in favor of FGF18 involvement in the process. Previous investigation had 
consistently indicated that FGF18 expression was located principally in interstitial tissue of 
distal lung areas in the mouse (22). Furthermore, FGF18 absence from perivascular or peri-
airway wall tissue where elastin is also abundant, is in favor of specific involvement for 
alveolarization at this stage of lung development. 
In a second step, human CDH lungs were compared to age-matched controls. We 
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found low FGF18 protein level in CDH lungs, with failure to increase in late pregnancy. 
Consistently, lowered FGF18 expression was found also in the ovine sDH model and in the 
nitrofen model in rats. The absence of change in FGFR3 expression in sDH indicates 
impairment of signaling at the ligand level, not the receptor level. Secondary septation was 
begun in humans and advanced in sheep at stages when FGF18 was determined in CDH. 
Impaired expression is therefore likely to be related with impairment of this process. In the 
rat, in contrast, the process of secondary septation was not yet initiated at the stage when 
the study was performed. Nevertheless, both elastin and FGF18 transcripts were decreased 
in the nitrofen model, which suggests disturbance in the prenatal formation of saccular walls. 
In rat lung, FGF18 presents two developmental peaks, a 2-fold prenatal increase between 
fetal days 19 and 21, and a 7-fold increase between postnatal days 2 and 3, separated by a 
transient fall at the time of birth (24). Changes reported here correspond to inhibition of the 
first rise that may therefore be related to the building of saccular walls. 
 
Elastic fiber density is diminished in diaphragmatic hernia 
Deposition of elastin fibers is intrinsic to the process of saccular and alveolar wall formation. 
It has been assumed that septal elastin provides a critical morphogenetic force in 
alveolarization (12). Consistent with previous reports, CDH lungs retained an immature 
appearance, and rare location of elastin at the tip of growing crests supports deficiency in 
secondary septa. Similar observations in the ovine sDH model indicate that lung 
compression by ascended viscera precipitates these disorders. We did not examine elastin 
deposits histologically in rat fetuses with nitrofen-induced CDH, but a previous investigation 
in the same model (21) had demonstrated paucity of elastin staining in the simplified terminal 
airways, similar to our report herein for human and sheep lungs.  
Decreased density of elastin fibers in distal parenchyma of CDH lungs is a novel 
finding of the present investigation. It indicates clearly that defective septation results from 
deficient elastin deposition. Decreased tropoelastin transcripts in the fetal sheep model 
indicated that impairment occurs at the pretranslational level. Reduced lung expansion 
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induced by lung fluid drainage has been reported to decrease tropoelastin mRNA 2.5-fold 
(38). Contradictory observations have been reported in the nitrofen model with either 
decreased (21 and present data) or increased (39) tropoelastin transcripts. The reason for 
the discrepancy between studies is unclear, but may be due to methodological differences 
(21). Moreover, reduced levels of tropoelastin transcripts in the nitrofen model were 
corroborated by reduction of desmosine content (indicative of cross-linked elastin) in the lung 
ipsilateral to hernia (21). Although no quantitative evaluation of elastin synthesis was 
performed in oligohydramnios, the absence of elastin deposits in alveolar septa reported at 
the ultrastuctural level in hypoplastic lungs with this disease (16) also suggests defective 
synthesis. Impaired elastogenesis in pulmonary septa therefore presents as a common 
feature in under-expanded hypoplastic lungs whatever the leading cause, and may therefore 
represent a direct consequence of insufficient lung-tissue tension. Although the present 
investigation does not demonstrate a causal relationship between FGF18 changes and 
impairment or restoration of alveolarization, developmental lung disturbances in prenatal 
mice lacking FGF18 (23), and the coordinated effects of FGF18 upon various proteins 
involved in elastogenesis by neonatal rat lung myofibroblasts (24) strongly argue in favor of 
such a link. The presence of FGF18 transcripts (22) and immunoreactive FGF18 (present 
data) in distal lung parenchyma reinforces this hypothesis. 
 
Treatments restore FGF18 expression and elastin deposition in CDH models 
FGF18 and elastin transcript and protein were restored or enhanced above control level by 
TO in sDH, and by vitamin A in the nitrofen model. It is well established that TO induces cell 
proliferation (40), a process enhanced for all cell types during alveolarization. A variety of 
growth factors have indeed been reported to increase in the lung in response to TO, 
including FGF7, TGF2, VEGF, IGFI and IGFII (9, 41-45). The notion that they play a crucial 
role in expansion-induced lung growth is strengthened by the observation that replacement 
of lung fluid, which contains growth factors, by saline, prevents lung growth normally 
observed following TO (46). Our finding of increased FGF18 mRNA and protein after TO 
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indicates stimulation by lung expansion, and adds FGF18 to growth factors listed above. 
With regard to elastin expression, our findings are in agreement with those from Joyce et al 
(38) showing a transient 2.5-fold increase of tropoelastin mRNA in the occluded fetal sheep 
lung. In this study, however, TO was performed on an intact lung, and was not combined with 
diaphragmatic hernia or drainage. Restoration of elastic fiber density and of lung histological 
aspect in sDH lungs indicates that TO not only restored overall lung growth, but also 
secondary septation, consistent with previous observation at the ultrastructural level (20). 
Data from other investigations indicate that this restoration appears sufficient to recover 
normal morphometric parameters, including radial alveolar count (27), gas-exchange surface 
area, and alveolar density (28). 
The second therapeutic approach consisting to use vitamin A in the nitrofen model is 
based on the importance of retinoids, including vitamin A and its active metabolites, in the 
alveolarization process (47). Several studies support the hypothesis that abnormalities within 
the retinoid-signalling pathway contribute to etiology of CDH (48). Moreover, decreased 
plasma retinol and retinol-binding protein levels have been reported in human newborns with 
CDH (49). Restoration of FGF18 and tropoelastin expressions by vitamin A in the lung of 
nitrofen-treated rat fetuses is in keeping with our previous finding that FGF18 and 
tropoelastin expression were both up-regulated subsequently to vitamin A administration to 
normal rat neonates (24). This suggests that the beneficial effect of vitamin A for pulmonary 
hypoplasia (33) might have resulted, among possible changes in other growth factors, from 
promotion of FGF18 expression. However, it should be emphasized that in this model, lung 
hypoplasia and immaturity also occur in pups that do not develop CDH. Although less 
marked, the morphology of lungs of fetuses without hernia was reported to be similar to that 
of CDH lungs, including paucity of elastic fiber deposits in septa (21). In agreement with this 
observation, we found reduced FGF18 and tropoelastin expression in nitrofen-treated fetuses 
devoid of hernia. Disorders could therefore result from pulmonary toxic effect(s) of nitrofen, 
independently of CDH. The transcription factor TTF-1, which is essential to lung 
morphogenesis, was down-regulated by nitrofen in fetal rat lungs independently of the 
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presence of CDH (50), and also in a time- and dose-dependent manner in cultured lung 
epithelial H-441 cells (51). Last, nitrofen is also believed to interfere with vitamin A signaling 
(52, 53). Therefore, it cannot be excluded that vitamin A supplementation counteracted 
pulmonary effects of nitrofen, including FGF18 and elastin changes, that were not direct 
consequences of hernia. Considering the use of vitamin A as a possible treatment of lung 
abnormalities in CDH therefore requires further evaluation of its actual benefits and safety. 
 
In conclusion, changes in FGF18 induced by CDH and treatments are novel and 
significant findings in the present study. Simultaneous correction of FGF18 and elastin 
defects by TO and vitamin A suggests that disordered alveolarization may result, at least in 
part, from FGF18 deficiency. 
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Figure legends 
 
Figure 1. Developmental changes of FGF18 protein in human fetal lung. Western blot 
analysis was performed in the lung of 14 fetuses without lung disease ranging from 14 to 37 
wk of pregnancy (fetal age). (A) Western blot demonstrating an obvious increase of FGF18 in 
late gestation (top); Ponceau S stain as loader control (bottom). (B) Densitometric analysis 
(arbitrary units, a.U.) showing that FGF18 was strongly up-regulated in saccular-alveolar 
stages (U27 wk) as compared with pseudoglandular-canalicular stages (T26 wk), and 
correlated exponentially with time (r= 0.865, p<0.001). 
 
Figure 2. FGF18 protein expression in CDH human lungs (ipsilateral lung). Western blot 
analysis was performed in the lung of 6 pairs of age-matched CDH and control fetuses. (A) 
Representative western blot showing FGF18 expression in 3 age-matched control and CDH 
lungs (top); Ponceau S stain as loader control (bottom). (B) densitometric analysis (arbitrary 
units, a.U.); individual values corrected for loading, and linear regression analysis. FGF18 
protein was lower in CDH lungs than corresponding control value for all pairs, and failed to 
increase with time. 
 
Figure 3. Weigert’s stain of elastin in control and CDH human lungs. Representative pictures 
are presented in two fetuses aged 29 wk (A, A’, control, B, B’, CDH) and two fetuses aged 33 
wk (C, C’ control, D, D’ CDH). Higher magnifications are from the same sections, but not 
necessarily from the same field. In controls, increase of the relative portion of airspaces and 
surge of secondary septa were observed with advancing gestation. Elastin, stained in black, 
was found at the tips of secondary crests (arrows), lining the surface (arrowheads), and in 
vessel walls (white arrowheads). CDH lungs ipsilateral to hernia presented thickened walls, 
with lack of changes between stages, but vessel labeling was unaffected. Crests and typical 
location of elastin at their tip were rarely observed. Bar = 200Zm in A-D, and 20Zm in A’-D’. 
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Figure 4. Determination of partial cDNA sequence of ovine FGF18. (A) Nucleotide sequence 
of the RT-PCR product and deduced amino acid sequence. (B) Alignment and comparison of 
ovine FGF18 amino acid sequence with those of human, mouse, and rat FGF18 proteins. 
Identical amino acyl residues are marked with asterisks. These data are accessible on line 
under GenBank accession # DQ336700. 
 
Figure 5. FGF18 and FGFR3 expression in fetal sheep lung with sDH and sDH+TO. (A) 
Real-time PCR analysis of FGF18 mRNA (mean ± se on 5, 6 and 4 individual samples in 
controls, sDH, and sDH+TO, respectively); FGF18 mRNA level was markedly decreased by 
sDH in ipsilateral lung only, and enhanced to about twice the control level by sDH+TO in both 
lungs. (B) Western blot analysis; ovine lung FGF18 migrated at the same apparent molecular 
weight as human lung FGF18 (hum); it was decreased by sDH and re-established by TO. (C) 
RT followed by real-time PCR analysis of FGFR3 mRNA; no significant difference was 
observed among the different groups. Non-parametric Kruskal-Wallis multiple group 
comparison, and two-group comparisons by Mann-Whitney U test. (a) Significant difference 
with controls for p<0.05; (b) significant difference with sDH for p<0.05. 
 
Figure 6. Weigert’s elastin stain in fetal sheep lung. (A, A’) control, (B, B’, C, C’) sDH, (D, D’) 
sDH+TO. A’, B’, C’ and D’ are enlargements of the dotted boxes in A, B, C and D, 
respectively. In control lungs, elastin regularly lined alveolar walls (black arrowheads) and 
focused at the tip of secondary septa with a punctate appearance (arrows). Although with 
variable morphology (B, B’ vs C,C’), sDH lungs ipsilateral to hernia displayed thickened 
walls, and altered elastin pattern. TO restored both lung parenchymal structure and elastin 
pattern. White arrowheads: blood vessels. Bar = 50Zm. 
 
Figure 7. Tropoelastin mRNA expression in fetal sheep lung with sDH and sDH+TO. Semi-
quantitative Northern blot analysis (mean ± sem on 5, 6 and 4 individual samples in controls, 
sDH, and sDH+TO, respectively). Tropoelastin mRNA level was decreased about half by 
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sDH in ipsilateral lung only, and enhanced to twice the control level by sDH+TO in both 
lungs. Non-parametric Kruskal-Wallis multiple group comparison, and two-group 
comparisons by Mann-Whitney U test. (a) Significant difference with controls for p<0.05; (b) 
significant difference with sDH for p <0.05; (c) significant difference with sDH for p <0.01. 
 
Figure 8. Tropoelastin and FGF18 mRNA expression in fetal rat lungs with nitrofen-induced 
CDH and CDH + vitamin A treatment (CDH+vitA). Both lungs were removed en-bloc and 
homogenized together for RNA extraction. Mean ± se of densitometric northern blot analysis 
on 6 individuals (21 day-old) in each group. Both transcripts were considerably reduced in 
CDH, and restored to control levels in CDH+vitA. Multiple group comparison by ANOVA and 
Fisher’s PLSD. (a) Significant difference from control group for p<0.05; (b) significant 
difference from control group for p<0.01; (c) significant difference from CDH+vitA group for 
p<0.001. 
 
Figure 9. Immunofluorescent labeling for FGF18 in distal lung. (A) 37-wk human fetus, (C) 
139d sheep fetus, (E) postnatal day 4 rat. (B, D, F) corresponding nuclear counterstaining. 
Dotted labeling was detected in the cytoplasm of cells with a stellate shape (arrowheads in A 
and C, insert in A, left insert in E), and was present in primary (* and left insert in E) and 
secondary septa (arrows, ** and right insert in E). Perivascular smooth-muscle cells  were 
negative (a : pulmonary artery). Arrows point to the same locations in parallel micrographs. 
Immunolabeling for alpha smooth muscle actin (SMA) in rat lung (G) displayed similar 
distribution pattern as FGF18. (H) Negative control for FGF18 antibody. Bar = 10Zm.  
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Table 1 
Characteristics of control and CDH human fetuses 
Number Fetal Age 
(weeks) 
Sex Syndrome Body weight 
(g) 
Lung weight / 
Body weight ratio 
1 14 M Single ventricle 115 ND 
2 16 F Thanatophoric dwarfism 143 0.026 
3 19 F Micromelic dwarfism 364 0.016 
4 21 M Cardiopathy 550 0.028 
5 22 F Cardiopathy 900 0.029 
6 24 F Hydrocephaly 840 0.031 
7 26 F Tetralogy of Fallot 1020 0.024 
8 27 F Pfeiffer’s syndrome 1300 0.019 
9 28 M Partial trisomy 13 1630 0.021 
10 28 F Achondroplasia 1520 0.021 
11 29 M Bourneville’s disease 1620 0.029 
12 31 F Cardiopathy 1720 0.024 
13 32 F Hydrocephaly 2500 0.022 
14 33 M Schizencepahly 2600 0.023 
15 33 M Trisomy 21 2450 0.026 
16 35 M Hydrocephaly 2000 0.020 
17 36 M Cardiopathy 2540 0.014 
18 37 F Spina-bifida 3140 0.017 
19 27 M CDH, left 1440 0.007 
20 29 M CDH, left 1100 0.003 
21 30 M CDH, left 2120 0.006 
22 31 F CDH, left 1900 0.004 
23 32 F CDH, left 1960 0.006 
24 33 M CDH, left 3300 0.002 
25 37 F CDH, right 3350 0.005 
Lung specimens were obtained from medical terminations of pregnancy except for subjects #23 and #25 
who were born alive and died immediately after birth without possible resuscitation. Lungs from fetuses 
with non-pulmonary diseases (#1 to 18) were used as controls. Fetal age is given as post-conceptional 
weeks. ND: not determined 
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Table 2 
Sequences of oligonucleotide primers used for real-time PCR 
 
Transcript Forward (5’-3’) Reverse (5’-3’) Expected Size 
(bp) 
FGF18    TGAACCGGAAAGGCAAGCT  TGACATCAGGGCTGTGTAGTTGT 100 
FGFR3    GACGGCACGCCCTACGT  CGTCCTCAAAGGTGACATTGC 99 
18S    AAGTCCCTGCCCTTTGTACACA  GATCCGAGGGCCTCACTAAAC 70 
Table 3 
Density of elastic fiber deposits in lung parenchyma of age-matched control 
and CDH human lungs 
 
Stage 
 
27 wk 
 
29 wk 
 
31 wk 
 
33 wk 
 
37 wk 
 
Elastin/Tissue (%) 
Control lungs 
 
0.43 ± 0.05 
 
0.54 ± 0.05 
 
1.80 ± 0.22 
 
0.79 ± 0.07 
 
1.55 ±0.26 
Elastin/Tissue (%) 
CDH lungs 
 
0.44 ± 0.07 
 
0.60 ± 0.07 
 
0.54 ± 0.16 
 
0.03 ± 0.02 
 
0.33 ± 0.10 
CDH/Control ratio 
 
1.02 
 
1.11 
 
0.30 
 
0.04 
 
0.21 
 
The proportion of total lung tissue surface-area represented by elastic fiber deposits was 
determined on tissue sections after Weigert’s stain, using image analysis and excluding 
vessel and airway elastin. Each value represents the average ratio ± se of 8 to 10 
determinations in fields taken at random for one individual lung (magnification x400). 
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Table 4 
Density of elastic fiber deposits in lung parenchyma of control, sDH, 
and sDH+TO sheep fetuses 
 
Groups 
 
Controls (4) 
 
sDH (4) 
 
sDH+TO (4) 
Elastin/Tissue (%) 
 
8.21 ± 1.92 
 
1. 2 ± 0.16 * 
 
11.67 ± 3.23 
¶
The percentage of lung tissue surface-area represented by elastic fiber deposits was 
determined on tissue sections after Weigert’s stain, using image analysis and excluding 
vessel and airway elastin. Each value is the mean ± se of data from 4 fetuses in each 
experimental group; the value in each individual lung was calculated as the average ratio of 5 
determinations in fields taken at random (magnification x200). Statistical comparison by non-
parametric Mann Whitney U test: * p<0.05 as compared with control group; ¶ p<0.05 as 
compared with sDH group; difference between sDH ±TO and control groups is not significant. 
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Figure 1 
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Figure 2 
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Figure 4 
 
ctg ctg tgc ttc cag gtt cag gtg ctg gtg gcc gag gag aac gtg gac ttc cgc atc cac    60  
L L C F Q V Q V L V A E E N V D F R I H
gtg gag aac cag acg cgg gct cgg gac gat gtg agc cgt aag cag ctg cgg ctg tac cag   120 
V E N Q T R A R D D V S R K Q L R L Y Q
ctc tac agc cgg acc agc ggg aag cac atc cag gtc ctg ggc cgc agg atc agc gcc cgc   180 
L Y S R T S G K H I Q V L G R R I S A R
ggc gag gac ggg gac aag tat gcc cag ctc cta gtg gag aca gat acc ttc ggt agt caa   240 
G E D G D K Y A Q L L V E T D T F G S Q
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Figure 5 
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Figure 7 
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Figure 8 
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